Upper gastrointestinal surgeons comment on NICE dyspepsia guidelinesBMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7486.308-b (Published 03 February 2005) Cite this as: BMJ 2005;330:308
- S M Griffin, president ([email protected]),
- D J Bowrey, specialist registrar,
- W H Allum, national clinical lead, on behalf of the Upper GI Cancer Services Improvement Partnership
- Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland at the Royal College of Surgeons, London WC2A 3PE
- Northern Oesophagogastric Cancer Unit, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP
- Royal Marsden Hospital SW3 6JJ
EDITOR—We believe that the recent dyspepsia management guidelines of the National Institute for Clinical Excellence (NICE) were poorly researched and that the recommendations are unsubstantiated.1
The guidelines committee comprised six primary care doctors, two gastroenterologists, one pharmacist, one patient representative, and one methodologist. No surgeons were represented, and the Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland was not registered as a stakeholder. This is surprising as upper gastrointestinal surgeons treat most patients with gastro-oesophageal cancer.
The guidelines advise primary care doctors (and community pharmacists) that endoscopy is indicated only as a primary …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial